HU9402744D0 - Antiviral peptides - Google Patents

Antiviral peptides

Info

Publication number
HU9402744D0
HU9402744D0 HU9402744A HU9402744A HU9402744D0 HU 9402744 D0 HU9402744 D0 HU 9402744D0 HU 9402744 A HU9402744 A HU 9402744A HU 9402744 A HU9402744 A HU 9402744A HU 9402744 D0 HU9402744 D0 HU 9402744D0
Authority
HU
Hungary
Prior art keywords
antiviral peptides
antiviral
peptides
Prior art date
Application number
HU9402744A
Other languages
Hungarian (hu)
Inventor
Colin William Greengrass
Stephen Derek Albert Street
Peter John Whittle
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929206462A external-priority patent/GB9206462D0/en
Priority claimed from GB939301638A external-priority patent/GB9301638D0/en
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Publication of HU9402744D0 publication Critical patent/HU9402744D0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
HU9402744A 1992-03-25 1993-03-13 Antiviral peptides HU9402744D0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929206462A GB9206462D0 (en) 1992-03-25 1992-03-25 Antiviral peptides
GB939301638A GB9301638D0 (en) 1993-01-27 1993-01-27 Antiviral peptides

Publications (1)

Publication Number Publication Date
HU9402744D0 true HU9402744D0 (en) 1994-12-28

Family

ID=26300586

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9402744A HU9402744D0 (en) 1992-03-25 1993-03-13 Antiviral peptides

Country Status (13)

Country Link
EP (1) EP0632808A1 (en)
JP (1) JPH07501556A (en)
KR (1) KR950700901A (en)
AU (1) AU3748393A (en)
BR (1) BR9306138A (en)
CA (1) CA2131154A1 (en)
CZ (1) CZ229594A3 (en)
FI (1) FI944428A0 (en)
HU (1) HU9402744D0 (en)
NO (1) NO943540L (en)
RU (1) RU94041225A (en)
SK (1) SK114094A3 (en)
WO (1) WO1993019059A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE143025T1 (en) * 1991-01-02 1996-10-15 Merrell Pharma Inc ANTIVIRAL COMPOUNDS
HUT73411A (en) * 1993-07-08 1996-07-29 Merrell Dow Pharma Difluoro statone analogs
DE69418050T2 (en) * 1993-09-09 1999-11-25 Merrell Pharmaceuticals Inc., Cincinnati ANTIVIRAL ANALOGS OF DIFLUOROSTATON
US6114380A (en) * 1995-12-18 2000-09-05 Merrell Pharmaceuticals Inc. Difluoro statone analogs
GB9601680D0 (en) 1996-01-27 1996-03-27 Pfizer Ltd Therapeutic agents
CA2320233C (en) * 1998-02-02 2004-07-27 Lg Chemical Ltd. Farnesyl transferase inhibitors having a piperidine structure and process for preparation thereof
US6809200B2 (en) 2000-07-28 2004-10-26 Pfizer Inc. Process for the preparation of pyrazolo[4,3-d]pyrimidin-7-one compounds and intermediates thereof
JP2008535876A (en) 2005-04-14 2008-09-04 エフ.ホフマン−ラ ロシュ アーゲー Aminopyrazole derivatives, their production and use as pharmaceutical formulations.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL91780A (en) * 1988-10-04 1995-08-31 Abbott Lab Renin inhibiting hexanoic acid amide derivatives, process for their preparation and pharmaceutical compositions containing them
IL92011A0 (en) * 1988-10-19 1990-07-12 Abbott Lab Heterocyclic peptide renin inhibitors
CA2010531A1 (en) * 1989-03-06 1990-09-06 Werner Neidhart Amino acid derivatives
WO1990012804A2 (en) * 1989-04-18 1990-11-01 The Upjohn Company Peptides having novel polar n-terminal groups
DE4001236A1 (en) * 1990-01-18 1991-07-25 Bayer Ag New oligopeptide(s) contg. 2-amino-2-methyl propionic acid residue - are antiviral agents for human or veterinary therapy including treatment of AIDS and ARC

Also Published As

Publication number Publication date
WO1993019059A1 (en) 1993-09-30
AU3748393A (en) 1993-10-21
RU94041225A (en) 1996-07-20
SK114094A3 (en) 1995-04-12
CA2131154A1 (en) 1993-09-30
CZ229594A3 (en) 1995-04-12
KR950700901A (en) 1995-02-20
FI944428A (en) 1994-09-23
EP0632808A1 (en) 1995-01-11
JPH07501556A (en) 1995-02-16
FI944428A0 (en) 1994-09-23
BR9306138A (en) 1998-06-23
NO943540L (en) 1994-11-21
NO943540D0 (en) 1994-09-23

Similar Documents

Publication Publication Date Title
GB2269176B (en) Peptides
ZA928511B (en) Peptides
GB2269526B (en) Fire-protecting suit
GB9202796D0 (en) Antiviral antibody
GB9226065D0 (en) Peptides
HU9402744D0 (en) Antiviral peptides
GB9219562D0 (en) Anti-viral peptides
GB9210744D0 (en) Antiviral peptides
PL299367A1 (en) Linear peptides
GB9204274D0 (en) Novel peptides
LV10286B (en) Peptide compounds
GB9206462D0 (en) Antiviral peptides
GB9301638D0 (en) Antiviral peptides
GB9211668D0 (en) Peptide compounds
GB9114507D0 (en) Antiviral peptides
GB9107752D0 (en) Antiviral peptides
GB9215176D0 (en) Antiviral combinations
GB9020663D0 (en) Antiviral peptides
ZA935126B (en) Peptides
GB9210074D0 (en) Peptides
GB9226074D0 (en) Peptide
GB8926549D0 (en) Antiviral peptides
GB8918108D0 (en) Antiviral peptides
GB9214409D0 (en) Antiviral agents
GB9214408D0 (en) Antiviral compounds